Equibles does not estimate personal net worth.
Earlier roles on record: CEO and Board Member at NeuroPace Inc (NPCE) until July 10, 2023. NeuroPace Inc reported in an 8-K filed June 28, 2023 that Michael Favet resigned as member of NeuroPace’s board of directors, effective July 10, 2023. NeuroPace Inc reported in an 8-K filed June 28, 2023 that Michael Favet resigned as Chief Executive Officer, effective July 10, 2023. The proxy statement of NeuroPace Inc reports total compensation of $2,179,174 for Michael Favet in fiscal 2023, including a base salary of $288,470. Disclosed compensation is on record for 4 fiscal years. Michael Favet has spoken on 3 earnings calls across 1 company, most recently for NeuroPace Inc on May 4, 2023. The companies whose calls Michael Favet spoke on are classified in the Healthcare sector.
“On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors (the “Board”), in each case effective as of July 10, 2023 (the “Separation Date”).”
“On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors (the “Board”), in each case effective as of July 10, 2023 (the “Separation Date”).”
“Today, I will highlight our first quarter performance and provide an update on our key business priorities for the year. I will then turn the call over to Rebecca to detail the financial results before we open the call to questions.”
“Today, I will highlight our fourth quarter performance and update you on the priorities we intend to focus on in 2023, before turning the call over to Rebecca to detail the financial results and open the call to questions.”
“I will start today's call with updates on our commercial progress and advancements with our clinical initiatives before turning the call over to Rebecca to provide details regarding our quarterly results and full year 2022 financial outlook.”
Start not stated–2023-07-10
Start not stated–2023-07-10
NPCE
Medical Devices · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | NeuroPace Inc (NPCE) | Former President and Chief Executive Officer | $288,470 | $2,179,174 |
| 2022 | NeuroPace Inc (NPCE) | Former President and Chief Executive Officer | $538,667 | $3,206,303 |
| 2021 | NeuroPace Inc (NPCE) | President and Chief Executive Officer | $505,833 | $2,076,341 |
| 2020 | NeuroPace Inc (NPCE) | President and Chief Executive Officer | $411,923 | $671,592 |
